Ortoma Obtains Granted Patent in the USA
Ortoma has been granted another patent by the US Patent and Trademark Office (USPTO). The patent relates to Ortoma Guide, which is a part of the innovative surgical system Ortoma Treatment Solution (OTS), and protects the system including accessories for navigated surgery.
The patent complements the company’s patent protection in the USA and covers all types of implants. The invention protected by the patent is one of the core technologies for the surgical system OTS, and is used to guide implants with high accuracy during surgery. The patent also covers accessories for OTS, that were launched last year and significantly reduce the preparation time for using the system during surgery.
The patent was granted on 16 March 2021 and is valid until October 2033 subject to payment of maintenance fees.
Ortoma – Improved Performance
For more information, please contact:
CEO Linus Byström, e-mail: firstname.lastname@example.org
About Ortoma AB (publ)
Ortoma AB develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. The purpose of the company's surgical system, Ortoma Treatment Solution™ (OTS) is to enable the surgeon to accurately measure and plan 3D surgery for the placement of a joint implant and during the surgery, to optimally position the implant in the patient. Ortoma’s surgical system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries - and thus better long-term survival rates for the implant. Another aim is to create a system that can be integrated easily into the processes and routines that are currently used in surgeries, thereby increasing efficiency. Ortoma’s B shares are noted on Spotligh Stock Market. Globally, more than 7.5 million orthopedic procedures are performed each year where OTS could be used in hip, knee and spinal surgery. In Sweden last year around 42,000 surgical procedures were performed involving hip, knee or spinal surgery.